Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

NXTC stock hub

NextCure, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NXTCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

35.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

NXTC

In the news

Latest news · NXTC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-132.4

P25 -106.6P50 -46.9P75 -3.1

ROIC-76

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NXTC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

174

Groups with data

Currency

USD

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001661059
Company name	NextCure, Inc.
Country	United States
Country code	US
Cusip	65343E207
Employees	40
Employees Change	-3%
Employees Change Percent	-6.98
Enterprise value	$9.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2019-05-09
Isin	US65343E2072
Last refreshed	2026-05-10
Market cap	$35.2M
Market cap category	Nano-Cap
Price	$9.76
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	NXTC
Website	https://www.nextcure.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-155.25%
FCF yield	-141.96%
P/B ratio	1.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-54.7M
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Profit Per Employee	$-1.4M
ROA	-66.71
Roa5y	-30.93
ROCE	-180.5
ROE	-132.4
Roe5y	-56.24
ROIC	-75.98

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	114.26%
Cagr3y	-20.02%
Cagr5y	-36.62%
EPS Growth Quarters	3
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$38M
Cash	$29.7M
Current Assets	$31.7M
Current Liabilities	$6.9M
Debt	$3.9M
Debt Equity	$0.15
Equity	$26.7M
Liabilities	$11.3M
Long Term Assets	$6.2M
Long Term Liabilities	$4.4M
Net Cash	$25.9M
Net Cash By Market Cap	$73.46
Net Cash Growth	-48.29%
Net Debt Equity	$-0.97
Tangible Book Value	$26.7M
Tangible Book Value Per Share	$7.41
WACC	10.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.61
Net Working Capital	$-4.9M
Quick ratio	4.32
Working Capital	$24.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-53%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	114.15%
200-day SMA	9.75
3Y total return	-48.85%
50-day SMA	11.13
50-day SMA vs 200-day SMA	50over200
5Y total return	-89.77%
All Time High	1,308
All Time High Change	-99.25%
All Time High Date	2019-11-05
All Time Low	2.69
All Time Low Change	263.1%
All Time Low Date	2025-04-10
ATR	1.18
Beta	1.43
Beta1y	1.51
Beta2y	1.06
Ch YTD	-31.22
High	10.2
High52	15.74
High52 Date	2025-11-24
High52ch	-37.99%
Low	9.76
Low52	4.44
Low52 Date	2025-05-08
Low52ch	119.82%
Ma50ch	-12.32%
Price vs 200-day SMA	0.06%
RSI	45.34
RSI Monthly	41.93
RSI Weekly	46.3
Sharpe ratio	1.2x
Sortino ratio	2.03
Total Return	-53%
Tr YTD	-31.22
Tr1m	-12.31%
Tr1w	4.27%
Tr3m	-12.07%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-1.82
Operating Income	$-56.1M
Price target	$23
Price Target Change	$136

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,277,865%
Float Percent	63.14%
Shares Insiders	1.27%
Shares Institutions	26.75%
Shares Out	3,607,555
Shares Qo Q	31.6%
Shares Yo Y	53%
Short Float	3.16%
Short Ratio	1.51
Short Shares	2

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-51.9M
Average Volume	70,559.35x
Bv Per Share	7.41
Ch1m	-12.31
Ch1w	4.27
Ch1y	114.1
Ch3m	-12.07
Ch3y	-48.85
Ch5y	-89.77
Ch6m	8.93
Change	-4.13%
Change From Open	-4.13
Close	10.18
Days Gap	0
Depreciation Amortization	1,814,000
Dollar Volume	92,638.2
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$-56.1M
EBITDA	$-54.3M
EPS	$-15.32
F Score	1
FCF	$-50M
FCF EV Yield	-534.81x
FCF Per Share	$-13.85
Financing CF	23,560,000
Fiscal Year End	December
Founded	2,015
Investing CF	19,762,000
Ipr	-34.93
Iprfo	-94.77
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2025-07-14
Last Split Type	Reverse
Last10k Filing Date	2026-03-05
Ma150	11.24
Ma150ch	-13.18%
Ma20	10.59
Ma20ch	-7.87%
Net CF	-6,660,000
Next Earnings Date	2026-08-06
Open	10.18
Optionable	No
Position In Range	0
Ppne	5,389,000
Price Date	2026-05-08
Ptbv Ratio	1.32
Relative Volume	0.13x
Share Based Comp	1,967,000
Tr6m	8.93%
Us State	Maryland
Volume	9,491.6

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NXTC pay a dividend?

Capital-return profile for this ticker.

Performance

NXTC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NXTC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+26.7%

Float: +63.1% of shares outstanding

Insider ownership

+1.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NXTC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.3

Neutral momentum band

Price vs 200-day MA

+0.1%

50/200-day relationship not available

Beta (5Y)

1.43

More volatile than the market

Sharpe ratio

1.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NXTC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NXTC stock rating?

NextCure, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NXTC analysis?

The full report lives at /stocks/NXTC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NXTC?

The latest report frames NXTC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NXTC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.